Growth hormone axis in chronic kidney disease
2008

Growth Hormone Axis in Chronic Kidney Disease

Sample size: 38 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mahesh Shefali, Kaskel Frederick

Primary Institution: Albert Einstein College of Medicine, Children’s Hospital at Montefiore

Hypothesis

Chronic kidney disease in children leads to growth hormone resistance and growth failure.

Conclusion

Children with chronic kidney disease often experience growth failure despite treatment with growth hormone.

Supporting Evidence

  • 36.9% of children with CKD had statutory growth impairment.
  • Children below age 6 benefited most from transplantation in demonstrating acceleration in linear growth.
  • Growth hormone treatment increased standardized height in children with CKD.

Takeaway

Kids with kidney problems often don't grow as tall as they should, but special medicine can help them grow better.

Methodology

The study reviewed data from children with chronic kidney disease and analyzed the effects of recombinant human growth hormone treatment on their growth.

Limitations

The final adult height achieved is still below the genetic target despite treatment.

Participant Demographics

Children with chronic kidney disease, including both boys and girls.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1007/s00467-007-0527-x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication